Prognostic factors related to surgical outcome of liver metastases of breast cancer

Journal of Breast Cancer

Volumn 16, Issue 2, 2013, Pages 184-192

  Kostov, Daniel V ^a   Kobakov, Georgi L ^b   Yankov, Daniel V ^a  

^a Naval Hospital Varna   (Bulgaria)

^b Varna Hospital of Oncological Diseases   (Bulgaria)

Author keywords

Breast neoplasms; Hepatectomy; Neoplasm metastasis

Indexed keywords

ANTHRACYCLINE; AROMATASE INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HORMONE RECEPTOR; NAVELBINE; TAXANE DERIVATIVE; TRASTUZUMAB;

ABDOMINAL BLEEDING; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; AXILLARY LYMPH NODE; BILE LEAKAGE; BREAST CANCER; CHEST INFECTION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; ECHOGRAPHY; FEMALE; FOLLOW UP; GASTROINTESTINAL TRANSIT; HISTOLOGY; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE; LIVER METASTASIS; LIVER RESECTION; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; RECURRENCE RISK; SURVIVAL RATE; TUMOR VOLUME; WOUND INFECTION;

EID: 84879927078     PISSN: 17386756     EISSN: None     Source Type: Journal    
DOI: 10.4048/jbc.2013.16.2.184     Document Type: Article

References (28)

1. Li XP, Meng ZQ, Guo WJ, Li J. Treatment for liver metastases from breast cancer: results and prognostic factors. World J Gastroenterol 2005;11:3782-7.
2. Elias D, Di Pietroantonio D. Surgery for liver metastases from breast cancer. HPB (Oxford) 2006;8:97-9.
3. Elias D, Lasser P, Spielmann M, May-Levin F, el Malt O, Thomas H, et al. Surgical and chemotherapeutic treatment of hepatic metastases from carcinoma of the breast. Surg Gynecol Obstet 1991;172:461-4.
4. Díaz R, Santaballa A, Munárriz B, Calderero V. Hepatic resection in breast cancer metastases: should it be considered standard treatment? Breast 2004;13:254-8.
5. Piccart MJ, Awada A, Hamilton A. Integration of new therapies into management of metastatic breast cancer: a focus on chemotherapy, treatment selection through use of molecular markers and newly developed biologic therapies in late clinical development. Am Soc Clin Oncol Educ Book 1999:526-39.
6. Aapro MS. Combining new agents with anthracyclines in metastatic breast cancer: an overview of recent findings. Semin Oncol 1999;26(1 Suppl 3):17-21.
7. Cardoso F, Costa A, Norton L, Cameron D, Cufer T, Fallowfield L, et al. 1st International consensus guidelines for advanced breast cancer (ABC 1). Breast 2012;21:242-52.
8. Vlastos G, Smith DL, Singletary SE, Mirza NQ, Tuttle TM, Popat RJ, et al. Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases. Ann Surg Oncol 2004;11:869-74.
9. Malassagne B, Goere D, Cherqui D, Fagniez PL. Surgical treatment of non-colorectal and non-endocrine liver metastases. Gastroenterol Clin Biol 2000;24:1177-85.
10. Pang YY. The Brisbane 2000 terminology of liver anatomy and resections. HPB 2000; 2:333-39. HPB (Oxford) 2002;4:99; author reply 99-100.
11. Marudanayagam R, Sandhu B, Perera MT, Taniere P, Coldham C, Bramhall S, et al. Hepatic resection for non-colorectal, non-neuroendocrine, non-sarcoma metastasis: a single-centre experience. HPB (Oxford) 2011;13:286-92.
12. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
13. Zinser JW, Hortobagyi GN, Buzdar AU, Smith TL, Fraschini G. Clinical course of breast cancer patients with liver metastases. J Clin Oncol 1987;5:773-82.
14. Insa A, Lluch A, Prosper F, Marugan I, Martinez-Agullo A, Garcia-Conde J. Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients. Breast Cancer Res Treat 1999;56:67-78.
15. Elias D, Maisonnette F, Druet-Cabanac M, Ouellet JF, Guinebretiere JM, Spielmann M, et al. An attempt to clarify indications for hepatectomy for liver metastases from breast cancer. Am J Surg 2003;185:158-64.
16. Sakamoto Y, Yamamoto J, Yoshimoto M, Kasumi F, Kosuge T, Kokudo N, et al. Hepatic resection for metastatic breast cancer: prognostic analysis of 34 patients. World J Surg 2005;29:524-7.
17. Adam R, Aloia T, Krissat J, Bralet MP, Paule B, Giacchetti S, et al. Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg 2006;244:897-907.
18. Adam R, Chiche L, Aloia T, Elias D, Salmon R, Rivoire M, et al. Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Ann Surg 2006;244:524-35.
19. Cassera MA, Hammill CW, Ujiki MB, Wolf RF, Swanström LL, Hansen PD. Surgical management of breast cancer liver metastases. HPB (Oxford) 2011;13:272-8.
20. Abbott DE, Brouquet A, Mittendorf EA, Andreou A, Meric-Bernstam F, Valero V, et al. Resection of liver metastases from breast cancer: estrogen receptor status and response to chemotherapy before metastasectomy define outcome. Surgery 2012;151:710-6.
21. Earle SA, Perez EA, Gutierrez JC, Sleeman D, Livingstone AS, Franceschi D, et al. Hepatectomy enables prolonged survival in select patients with isolated noncolorectal liver metastasis. J Am Coll Surg 2006;203:436-46.
22. Thelen A, Benckert C, Jonas S, Lopez-Hänninen E, Sehouli J, Neumann U, et al. Liver resection for metastases from breast cancer. J Surg Oncol 2008;97:25-9.
23. Martinez SR, Young SE, Giuliano AE, Bilchik AJ. The utility of estrogen receptor, progesterone receptor, and Her-2/neu status to predict survival in patients undergoing hepatic resection for breast cancer metastases. Am J Surg 2006;191:281-3.
24. Cady B, Stone MD, McDermott WV Jr, Jenkins RL, Bothe A Jr, Lavin PT, et al. Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases. Arch Surg 1992;127:561-8.
25. Gunabushanam G, Sharma S, Thulkar S, Srivastava DN, Rath GK, Julka PK, et al. Radiofrequency ablation of liver metastases from breast cancer: results in 14 patients. J Vasc Interv Radiol 2007;18(1 Pt 1):67-72.
26. Vogl TJ, Farshid P, Naguib NN, Zangos S. Thermal ablation therapies in patients with breast cancer liver metastases: a review. Eur Radiol 2013;23:797-804.
27. Cianni R, Pelle G, Notarianni E, Saltarelli A, Rabuffi P, Bagni O, et al. Radioembolisation with (90)Y-labelled resin microspheres in the treatment of liver metastasis from breast cancer. Eur Radiol 2013;23:182-9.
28. Collettini F, Golenia M, Schnapauff D, Poellinger A, Denecke T, Wust P, et al. Percutaneous computed tomography-guided high-dose-rate brachytherapy ablation of breast cancer liver metastases: initial experience with 80 lesions. J Vasc Interv Radiol 2012;23:618-26.